QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 p3-health-partners-prices-422m-private-placement-of-674m-units-at-a-price-of-06270-per-unit-with-certain-institutional-investors

P3 Health Partners Inc. (NASDAQ:PIII), a patient- centered and physician-led population health management company (the "Com...

 p3-health-partners-names-aric-coffman-ceo-effective-may-8-2024-succeeding-sherif-abdou-p3s-co-founder

P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), today named Dr. Aric Coffman as P3's Chief E...

 p3-health-partners-q1-2024-gaap-eps-016-misses-011-estimate-sales-388488m-beat-352466m-estimate

P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of ...

 btig-downgrades-p3-health-partners-to-neutral

BTIG analyst David Larsen downgrades P3 Health Partners (NASDAQ:PIII) from Buy to Neutral.

 p3-health-partners-q4-eps-022-misses-011-estimate-sales-34686m-beat-30297m-estimate

P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of ...

 earnings-scheduled-for-march-28-2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

 lake-street-maintains-buy-on-p3-health-partners-lowers-price-target-to-45

Lake Street analyst Brooks O'Neil maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from...

 why-clover-health-investments-shares-are-trading-higher-by-11-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported b...

 p3-health-partners-says-management-anticipates-that-it-will-be-disclosing-in-the-form-10-k-substantial-doubt-about-the-cos-ability-to-continue-as-a-going-concern-as-the-co-does-not-currently-have-sufficient-cash-resources-to-support-its-planned-operations-for-at-least-12-months

- SEC Filing